Nycomed Submits Daxas Lung Drug for EU Approval

Nycomed has submitted Daxas, its “smoker’s lung” drug, for regulatory approval in Europe and is preparing for a submission in the United States, the unlisted Swiss drugmaker said.
ForexPros.com